An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in vivo

References

• Berndt N, Hamilton AD, Sebti SM. Targeting protein prenylation for cancer therapy. Nat Rev Cancer 2011; 11:775 - 91; http://dx.doi.org/10.1038/nrc3151; PMID: 22020205
   PubMed Web of Science ®Google Scholar
• Gao J, Liao J, Yang GY. CAAX-box protein, prenylation process and carcinogenesis. Am J Transl Res 2009; 1:312 - 25; PMID: 19956441
   PubMed Web of Science ®Google Scholar
• Ahearn IM, Haigis K, Bar-Sagi D, Philips MR. Regulating the regulator: post-translational modification of RAS. Nat Rev Mol Cell Biol 2012; 13:39 - 51; http://dx.doi.org/10.1038/nrm3255; PMID: 22189424
   PubMed Web of Science ®Google Scholar
• Casey PJ, Seabra MC. Protein prenyltransferases. J Biol Chem 1996; 271:5289 - 92; http://dx.doi.org/10.1074/jbc.271.10.5289; PMID: 8621375
   PubMed Web of Science ®Google Scholar
• Otto JC, Kim E, Young SG, Casey PJ. Cloning and characterization of a mammalian prenyl protein-specific protease. J Biol Chem 1999; 274:8379 - 82; http://dx.doi.org/10.1074/jbc.274.13.8379; PMID: 10085068
   PubMed Web of Science ®Google Scholar
• Dai Q, Choy E, Chiu V, Romano J, Slivka SR, Steitz SA, Michaelis S, Philips MR. Mammalian prenylcysteine carboxyl methyltransferase is in the endoplasmic reticulum. J Biol Chem 1998; 273:15030 - 4; http://dx.doi.org/10.1074/jbc.273.24.15030; PMID: 9614111
   PubMed Web of Science ®Google Scholar
• Wright LP, Court H, Mor A, Ahearn IM, Casey PJ, Philips MR. Topology of mammalian isoprenylcysteine carboxyl methyltransferase determined in live cells with a fluorescent probe. Mol Cell Biol 2009; 29:1826 - 33; http://dx.doi.org/10.1128/MCB.01719-08; PMID: 19158273
   PubMed Web of Science ®Google Scholar
• Yang J, Kulkarni K, Manolaridis I, Zhang Z, Dodd RB, Mas-Droux C, Barford D. Mechanism of isoprenylcysteine carboxyl methylation from the crystal structure of the integral membrane methyltransferase ICMT. Mol Cell 2011; 44:997 - 1004; http://dx.doi.org/10.1016/j.molcel.2011.10.020; PMID: 22195972
   PubMed Web of Science ®Google Scholar
• Bergo MO, Leung GK, Ambroziak P, Otto JC, Casey PJ, Gomes AQ, Seabra MC, Young SG. Isoprenylcysteine carboxyl methyltransferase deficiency in mice. J Biol Chem 2001; 276:5841 - 5; http://dx.doi.org/10.1074/jbc.C000831200; PMID: 11121396
   PubMed Web of Science ®Google Scholar
• Bergo MO, Gavino BJ, Hong C, Beigneux AP, McMahon M, Casey PJ, Young SG. Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. J Clin Invest 2004; 113:539 - 50; http://dx.doi.org/10.1172/JCI200418829; PMID: 14966563
   PubMed Web of Science ®Google Scholar
• Wahlstrom AM, Cutts BA, Liu M, Lindskog A, Karlsson C, Sjogren AK, Andersson KM, Young SG, Bergo MO. Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease. Blood 2008; 112:1357 - 65; http://dx.doi.org/10.1182/blood-2007-06-094060; PMID: 18502828
   PubMed Web of Science ®Google Scholar
• Baines AT, Xu D, Der CJ. Inhibition of Ras for cancer treatment: the search continues. Future Med Chem 2011; 3:1787 - 808; http://dx.doi.org/10.4155/fmc.11.121; PMID: 22004085
   PubMed Web of Science ®Google Scholar
• Slebos RJ, Hoppin JA, Tolbert PE, Holly EA, Brock JW, Zhang RH, Bracci PM, Foley J, Stockton P, McGregor LM, et al. K-ras and p53 in pancreatic cancer: association with medical history, histopathology, and environmental exposures in a population-based study. Cancer Epidemiol Biomarkers Prev 2000; 9:1223 - 32; PMID: 11097231
   PubMed Web of Science ®Google Scholar
• John J, Sohmen R, Feuerstein J, Linke R, Wittinghofer A, Goody RS. Kinetics of interaction of nucleotides with nucleotide-free H-ras p21. Biochemistry 1990; 29:6058 - 65; http://dx.doi.org/10.1021/bi00477a025; PMID: 2200519
   PubMed Web of Science ®Google Scholar
• Ostrem JM, Peters U, Sos ML, Wells JA, Shokat KM. K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions. Nature 2013; 503:548 - 51; http://dx.doi.org/10.1038/nature12796; PMID: 24256730
   PubMed Web of Science ®Google Scholar
• James GL, Goldstein JL, Brown MS. Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro. J Biol Chem 1995; 270:6221 - 6; http://dx.doi.org/10.1074/jbc.270.11.6221; PMID: 7890759
   PubMed Web of Science ®Google Scholar
• Whyte DB, Kirschmeier P, Hockenberry TN, Nunez-Oliva I, James L, Catino JJ, Bishop WR, Pai JK. K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors. J Biol Chem 1997; 272:14459 - 64; http://dx.doi.org/10.1074/jbc.272.22.14459; PMID: 9162087
   PubMed Web of Science ®Google Scholar
• Winter-Vann AM, Baron RA, Wong W, dela Cruz J, York JD, Gooden DM, Bergo MO, Young SG, Toone EJ, Casey PJ. A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells. Proc Natl Acad Sci U S A 2005; 102:4336 - 41; http://dx.doi.org/10.1073/pnas.0408107102; PMID: 15784746
   PubMed Web of Science ®Google Scholar
• Wang M, Tan W, Zhou J, Leow J, Go M, Lee HS, Casey PJ. A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells. J Biol Chem 2008; 283:18678 - 84; http://dx.doi.org/10.1074/jbc.M801855200; PMID: 18434300
   PubMed Web of Science ®Google Scholar
• Cushman I, Casey PJ. Role of isoprenylcysteine carboxylmethyltransferase-catalyzed methylation in Rho function and migration. J Biol Chem 2009; 284:27964 - 73; http://dx.doi.org/10.1074/jbc.M109.025296; PMID: 19651782
   PubMed Web of Science ®Google Scholar
• Cushman I, Casey PJ. RHO methylation matters: a role for isoprenylcysteine carboxylmethyltransferase in cell migration and adhesion. Cell Adh Migr 2011; 5:11 - 5; http://dx.doi.org/10.4161/cam.5.1.13196; PMID: 20798596
   PubMed Web of Science ®Google Scholar
• Go ML, Leow JL, Gorla SK, Schüller AP, Wang M, Casey PJ. Amino derivatives of indole as potent inhibitors of isoprenylcysteine carboxyl methyltransferase. J Med Chem 2010; 53:6838 - 50; http://dx.doi.org/10.1021/jm1002843; PMID: 20809634
   PubMed Web of Science ®Google Scholar
• Ramanujulu PM, Yang T, Yap SQ, Wong FC, Casey PJ, Wang M, Go ML. Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt). Eur J Med Chem 2013; 63:378 - 86; http://dx.doi.org/10.1016/j.ejmech.2013.02.007; PMID: 23514631
   PubMed Web of Science ®Google Scholar
• Bergo MO, Leung GK, Ambroziak P, Otto JC, Casey PJ, Young SG. Targeted inactivation of the isoprenylcysteine carboxyl methyltransferase gene causes mislocalization of K-Ras in mammalian cells. J Biol Chem 2000; 275:17605 - 10; http://dx.doi.org/10.1074/jbc.C000079200; PMID: 10747846
   PubMed Web of Science ®Google Scholar
• Davies BS, Fong LG, Yang SH, Coffinier C, Young SG. The posttranslational processing of prelamin A and disease. Annu Rev Genomics Hum Genet 2009; 10:153 - 74; http://dx.doi.org/10.1146/annurev-genom-082908-150150; PMID: 19453251
   PubMed Web of Science ®Google Scholar
• Ibrahim MX, Sayin VI, Akula MK, Liu M, Fong LG, Young SG, Bergo MO. Targeting isoprenylcysteine methylation ameliorates disease in a mouse model of progeria. Science 2013; 340:1330 - 3; http://dx.doi.org/10.1126/science.1238880; PMID: 23686339
   PubMed Web of Science ®Google Scholar
• Wang M, Hossain MS, Tan W, Coolman B, Zhou J, Liu S, Casey PJ. Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth. Oncogene 2010; 29:4959 - 70; http://dx.doi.org/10.1038/onc.2010.247; PMID: 20622895
   PubMed Web of Science ®Google Scholar
• Zhu WL, Hossain MS, Guo DY, Liu S, Tong H, Khakpoor A, Casey PJ, Wang M. A role for Rac3 GTPase in the regulation of autophagy. J Biol Chem 2011; 286:35291 - 8; http://dx.doi.org/10.1074/jbc.M111.280990; PMID: 21852230
   PubMed Web of Science ®Google Scholar
• Kimura S, Noda T, Yoshimori T. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3. Autophagy 2007; 3:452 - 60; PMID: 17534139
   PubMed Web of Science ®Google Scholar
• Yang YP, Liang ZQ, Gu ZL, Qin ZH. Molecular mechanism and regulation of autophagy. Acta Pharmacol Sin 2005; 26:1421 - 34; http://dx.doi.org/10.1111/j.1745-7254.2005.00235.x; PMID: 16297339
   PubMed Web of Science ®Google Scholar
• Wang M, Khoo YM, Zhou J, Casey P, Lee HS. A high-performance liquid chromatography method for the quantification of cysmethynil, an inhibitor of isoprenylcysteine carboxylmethyl transferase, in mouse plasma. J Chromatogr B Analyt Technol Biomed Life Sci 2009; 877:553 - 7; http://dx.doi.org/10.1016/j.jchromb.2008.12.067; PMID: 19157999
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Hagiwara K. Epidermal growth factor receptor (EGFR) mutation and personalized therapy in advanced nonsmall cell lung cancer (NSCLC). Target Oncol 2013; 8:27 - 33; http://dx.doi.org/10.1007/s11523-013-0258-9; PMID: 23361373
   PubMed Web of Science ®Google Scholar
• Ono M, Hirata A, Kometani T, Miyagawa M, Ueda S, Kinoshita H, Fujii T, Kuwano M. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation. Mol Cancer Ther 2004; 3:465 - 72; PMID: 15078990
   PubMed Web of Science ®Google Scholar
• Chou TC. Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev 2006; 58:621 - 81; http://dx.doi.org/10.1124/pr.58.3.10; PMID: 16968952
   PubMed Web of Science ®Google Scholar
• Han W, Pan H, Chen Y, Sun J, Wang Y, Li J, Ge W, Feng L, Lin X, Wang X, et al. EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells. PLoS One 2011; 6:e18691; http://dx.doi.org/10.1371/journal.pone.0018691; PMID: 21655094
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhang Y, Zhang L, Ren X, Huber-Keener KJ, Liu X, Zhou L, Liao J, Keihack H, Yan L, et al. MK-2206, a novel allosteric inhibitor of Akt, synergizes with gefitinib against malignant glioma via modulating both autophagy and apoptosis. Mol Cancer Ther 2012; 11:154 - 64; http://dx.doi.org/10.1158/1535-7163.MCT-11-0606; PMID: 22057914
   PubMed Web of Science ®Google Scholar
• Dragowska WH, Weppler SA, Wang JC, Wong LY, Kapanen AI, Rawji JS, Warburton C, Qadir MA, Donohue E, Roberge M, et al. Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer. PLoS One 2013; 8:e76503; http://dx.doi.org/10.1371/journal.pone.0076503; PMID: 24146879
   PubMed Web of Science ®Google Scholar
• Al-Lazikani B, Banerji U, Workman P. Combinatorial drug therapy for cancer in the post-genomic era. Nat Biotechnol 2012; 30:679 - 92; http://dx.doi.org/10.1038/nbt.2284; PMID: 22781697
   PubMed Web of Science ®Google Scholar
• Delbaldo C, Michiels S, Syz N, Soria JC, Le Chevalier T, Pignon JP. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis. JAMA 2004; 292:470 - 84; http://dx.doi.org/10.1001/jama.292.4.470; PMID: 15280345
   PubMed Web of Science ®Google Scholar
• Zimmermann GR, Lehár J, Keith CT. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov Today 2007; 12:34 - 42; http://dx.doi.org/10.1016/j.drudis.2006.11.008; PMID: 17198971
   PubMed Web of Science ®Google Scholar
• Sakuma Y, Matsukuma S, Nakamura Y, Yoshihara M, Koizume S, Sekiguchi H, Saito H, Nakayama H, Kameda Y, Yokose T, et al. Enhanced autophagy is required for survival in EGFR-independent EGFR-mutant lung adenocarcinoma cells. Lab Invest 2013; 93:1137 - 46; http://dx.doi.org/10.1038/labinvest.2013.102; PMID: 23938604
   PubMed Web of Science ®Google Scholar
• Zhai B, Hu F, Jiang X, Xu J, Zhao D, Liu B, Pan S, Dong X, Tan G, Wei Z, et al. Inhibition of akt reverses the acquired resistance to sorafenib by switching protective autophagy to autophagic cell death in hepatocellular carcinoma. Mol Cancer Ther 2014; 13:1589 - 98; http://dx.doi.org/10.1158/1535-7163.MCT-13-1043; PMID: 24705351
   PubMed Web of Science ®Google Scholar
• Court H, Amoyel M, Hackman M, Lee KE, Xu R, Miller G, Bar-Sagi D, Bach EA, Bergö MO, Philips MR. Isoprenylcysteine carboxylmethyltransferase deficiency exacerbates KRAS-driven pancreatic neoplasia via Notch suppression. J Clin Invest 2013; 123:4681 - 94; http://dx.doi.org/10.1172/JCI65764; PMID: 24216479
   PubMed Web of Science ®Google Scholar
• Hamer PJ, Trimpe KL, Pullano T, Ng S, LaVecchio JA, Petit DA, DeLellis R, Wolfe H, Carney WP. Production and characterization of anti-RAS p21 monoclonal antibodies. Hybridoma 1990; 9:573 - 87; http://dx.doi.org/10.1089/hyb.1990.9.573; PMID: 2076896
   PubMed Web of Science ®Google Scholar
• Ragnauth CD, Warren DT, Liu Y, McNair R, Tajsic T, Figg N, Shroff R, Skepper J, Shanahan CM. Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging. Circulation 2010; 121:2200 - 10; http://dx.doi.org/10.1161/CIRCULATIONAHA.109.902056; PMID: 20458013
   PubMed Web of Science ®Google Scholar
• Shiwarski DJ, Dagda RK, Chu CT. Red and Green Puncta Colocalization Macro. 2014
   Google Scholar
• Pampliega O, Orhon I, Patel B, Sridhar S, Díaz-Carretero A, Beau I, Codogno P, Satir BH, Satir P, Cuervo AM. Functional interaction between autophagy and ciliogenesis. Nature 2013; 502:194 - 200; http://dx.doi.org/10.1038/nature12639; PMID: 24089209
   PubMed Web of Science ®Google Scholar